CDC Webpage Update: The CDC has revised its webpage to indicate that vaccines may potentially contribute to autism, stating that previous claims asserting vaccines do not cause autism are not evidence-based and warrant further investigation.
Ongoing Investigations: The Department of Health and Human Services is conducting a comprehensive assessment of autism causes, exploring biological mechanisms that may link early childhood vaccinations to autism, including factors like aluminum adjuvants and neuroinflammation.
Political Context: The revision of the webpage comes amid political discussions, particularly during Health Secretary Robert F. Kennedy Jr.’s Senate confirmation process, where he assured that the CDC would not remove statements denying a vaccine-autism link.
Trust in CDC: The changes have raised concerns about the CDC's credibility as a scientific authority, leading to resignations of senior officials who cited the politicization of science within the agency.
Wall Street analysts forecast VHT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VHT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast VHT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VHT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 294.370
Low
Averages
High
Current: 294.370
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.